Aquestive Therapeutics (AQST) Payables (2017 - 2026)
Aquestive Therapeutics (AQST) recorded Payables of $8.82 million in Q3 2026, down 18.8% from $10.87 million a year earlier and down 1.6% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, Aquestive Therapeutics reported Payables of $29.86 million, up 190.3% from FY2024.
- Annual Payables has a five-year compound annual growth rate of 33.3% (FY2020 to FY2025).
- Across earlier years, Payables came in at $10.29 million in FY2024 (+15.2%), $8.93 million in FY2023 (-10.3%), $9.95 million in FY2022 (+19.6%) and $8.31 million in FY2021 (+17.3%).
- The Q3 2026 figure is the lowest quarterly Payables since Q3 2024.
- On a year-over-year basis, Payables has declined for three consecutive quarters, with growth averaging 41.1% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 190.3% in Q4 2025, against a decline of 46.7% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $8.97 million (Q2 2026), $11.89 million (Q1 2026) and $29.86 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Aquestive Therapeutics | 445.70 Mn | 24.96 Mn | 3.95 Mn | 8.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 8.82 Mn |
| Jun 30, 2026 | 8.97 Mn |
| Mar 31, 2026 | 11.89 Mn |
| Dec 31, 2025 | 29.86 Mn |
| Sep 30, 2025 | 10.87 Mn |
| Jun 30, 2025 | 11.95 Mn |
| Mar 31, 2025 | 12.28 Mn |
| Dec 31, 2024 | 10.29 Mn |
| Sep 30, 2024 | 7.57 Mn |
| Jun 30, 2024 | 5.70 Mn |
| Mar 31, 2024 | 10.52 Mn |
| Dec 31, 2023 | 8.93 Mn |
| Sep 30, 2023 | 9.99 Mn |
| Jun 30, 2023 | 10.69 Mn |
| Mar 31, 2023 | 12.44 Mn |
| Dec 31, 2022 | 9.95 Mn |
| Sep 30, 2022 | 11.07 Mn |
| Jun 30, 2022 | 8.89 Mn |
| Mar 31, 2022 | 8.50 Mn |
| Dec 31, 2021 | 8.31 Mn |
API Access
Aquestive Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();